Rite Aid EPS - Earnings per Share 2010-2022 | RAD

Rite Aid eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Rite Aid Annual EPS
2022 $-9.96
2021 $-1.69
2020 $-8.50
2019 $-7.99
2018 $17.98
2017 $0.08
2016 $3.20
2015 $41.60
2014 $4.60
2013 $2.40
2012 $-8.60
2011 $-12.80
2010 $-11.80
2009 $-69.80
Rite Aid Quarterly EPS
2022-08-31 $-6.07
2022-05-31 $-2.03
2022-02-28 $-7.19
2021-11-30 $-0.67
2021-08-31 $-1.86
2021-05-31 $-0.24
2021-02-28 $-0.33
2020-11-30 $0.08
2020-08-31 $-0.25
2020-05-31 $-1.19
2020-02-29 $-6.09
2019-11-30 $0.96
2019-08-31 $-1.49
2019-05-31 $-1.88
2019-02-28 $-5.17
2018-11-30 $-0.09
2018-08-31 $-6.80
2018-05-31 $4.07
2018-02-28 $14.58
2017-11-30 $1.60
2017-08-31 $3.20
2017-05-31 $-1.40
2017-02-28 $-0.32
2016-11-30 $0.20
2016-08-31 $0.20
2016-05-31 $0.00
2016-02-29 $1.20
2015-11-30 $1.20
2015-08-31 $0.40
2015-05-31 $0.40
2015-02-28 $35.80
2014-11-30 $2.00
2014-08-31 $2.60
2014-05-31 $0.80
2014-02-28 $1.40
2013-11-30 $0.80
2013-08-31 $0.60
2013-05-31 $1.80
2013-02-28 $2.60
2012-11-30 $1.40
2012-08-31 $-1.00
2012-05-31 $-0.60
2012-02-29 $-3.80
2011-11-30 $-1.20
2011-08-31 $-2.20
2011-05-31 $-1.40
2011-02-28 $-4.60
2010-11-30 $-1.80
2010-08-31 $-4.60
2010-05-31 $-1.80
2010-02-28 $-4.80
2009-11-30 $-2.00
2009-08-31 $-2.80
2009-05-31 $-2.20
2009-02-28 $-54.40
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $0.275B $24.568B
Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $125.204B 11.13
Herbalife (HLF) United States $2.145B 5.33
GNC Holdings (GNC) United States $0.000B 0.00